USD907760S1 - Orally ingestible tablet - Google Patents

Orally ingestible tablet Download PDF

Info

Publication number
USD907760S1
USD907760S1 US29/591,537 US201729591537F USD907760S US D907760 S1 USD907760 S1 US D907760S1 US 201729591537 F US201729591537 F US 201729591537F US D907760 S USD907760 S US D907760S
Authority
US
United States
Prior art keywords
orally ingestible
ingestible tablet
tablet
orally
view
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US29/591,537
Inventor
Daniel Hassan
Fred Hassan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Original Assignee
Societe des Produits Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA filed Critical Societe des Produits Nestle SA
Priority to US29/591,537 priority Critical patent/USD907760S1/en
Assigned to Physician's Seal, LLC reassignment Physician's Seal, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HASSAN, Daniel, HASSAN, FRED
Assigned to Société des Produits Nestlé S.A. reassignment Société des Produits Nestlé S.A. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: Physician's Seal, LLC
Application granted granted Critical
Publication of USD907760S1 publication Critical patent/USD907760S1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Description

FIG. 1 is a top front perspective view of an orally ingestible tablet;
FIG. 2 is a front view thereof, the back view being a mirror image;
FIG. 3 is a top view thereof;
FIG. 4 is bottom view thereof;
FIG. 5 is a right side view thereof; and,
FIG. 6 is a left side view thereof.
The broken lines do not form part of the claimed design.
The “REM” logo forming part of the claimed design is a trademark of Physician's Seal, LLC.

Claims (1)

    CLAIM
  1. The ornamental design of an orally ingestible tablet, substantially as shown and described.
US29/591,537 2017-01-20 2017-01-20 Orally ingestible tablet Active USD907760S1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US29/591,537 USD907760S1 (en) 2017-01-20 2017-01-20 Orally ingestible tablet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29/591,537 USD907760S1 (en) 2017-01-20 2017-01-20 Orally ingestible tablet

Publications (1)

Publication Number Publication Date
USD907760S1 true USD907760S1 (en) 2021-01-12

Family

ID=74067479

Family Applications (1)

Application Number Title Priority Date Filing Date
US29/591,537 Active USD907760S1 (en) 2017-01-20 2017-01-20 Orally ingestible tablet

Country Status (1)

Country Link
US (1) USD907760S1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD918377S1 (en) * 2017-10-11 2021-05-04 Johnson & Johnson Consumer Inc. Tablet
USD947358S1 (en) * 2019-03-19 2022-03-29 Novo Nordisk A/S Pill
USD1017017S1 (en) * 2021-12-20 2024-03-05 Pfizer Inc. Pill

Citations (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD430285S (en) * 1999-04-16 2000-08-29 Merck & Co., Inc. Tablet
USD433121S (en) * 1999-02-23 2000-10-31 Pfizer Inc Pharmaceutical tablet
USD433122S (en) * 1999-02-23 2000-10-31 Pfizer Inc. Pharmaceutical tablet
USD434136S (en) * 1999-02-23 2000-11-21 Pfizer Inc Pharmaceutical tablet
USD434135S (en) * 1999-02-23 2000-11-21 Pfizer Inc Pharmaceutical tablet
USD459798S1 (en) * 2001-03-26 2002-07-02 Aventis Pharma S.A. Pill tablet
USD515202S1 (en) * 2004-07-19 2006-02-14 Merck & Co., Inc Tablet
USD564086S1 (en) * 2005-05-30 2008-03-11 Nycomed Pharma A/S Tablet
USD636070S1 (en) * 2010-02-26 2011-04-12 Astrazeneca Ab Tablet
USD671636S1 (en) * 2010-04-23 2012-11-27 Daiichi Sankyo Company, Limited Pharmaceutical tablet
USD685460S1 (en) * 2009-08-27 2013-07-02 Astrazeneca Ab Tablet
USD735315S1 (en) * 2012-06-25 2015-07-28 Celgene Corporation Pharmaceutical tablet
USD754841S1 (en) * 2012-02-03 2016-04-26 Johnson & Johnson Consumer Inc. Oral dosage form
USD755949S1 (en) * 2013-07-30 2016-05-10 Reckitt Benckiser Llc Tablet
USD773641S1 (en) * 2009-09-15 2016-12-06 Johnson & Johnson Consumer Inc. Oral dosage form
USD787042S1 (en) * 2015-04-28 2017-05-16 Celgene Corporation Pharmaceutical tablet
USD813372S1 (en) * 2017-02-22 2018-03-20 Celgene Corporation Pharmaceutical tablet
USD835257S1 (en) * 2017-02-22 2018-12-04 Celgene Corporation Pharmaceutical tablet

Patent Citations (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD433121S (en) * 1999-02-23 2000-10-31 Pfizer Inc Pharmaceutical tablet
USD433122S (en) * 1999-02-23 2000-10-31 Pfizer Inc. Pharmaceutical tablet
USD434136S (en) * 1999-02-23 2000-11-21 Pfizer Inc Pharmaceutical tablet
USD434135S (en) * 1999-02-23 2000-11-21 Pfizer Inc Pharmaceutical tablet
USD430285S (en) * 1999-04-16 2000-08-29 Merck & Co., Inc. Tablet
USD434846S (en) * 1999-07-07 2000-12-05 Merck & Co., Inc. Tablet
USD459798S1 (en) * 2001-03-26 2002-07-02 Aventis Pharma S.A. Pill tablet
USD515202S1 (en) * 2004-07-19 2006-02-14 Merck & Co., Inc Tablet
USD564086S1 (en) * 2005-05-30 2008-03-11 Nycomed Pharma A/S Tablet
USD685460S1 (en) * 2009-08-27 2013-07-02 Astrazeneca Ab Tablet
USD773641S1 (en) * 2009-09-15 2016-12-06 Johnson & Johnson Consumer Inc. Oral dosage form
USD636070S1 (en) * 2010-02-26 2011-04-12 Astrazeneca Ab Tablet
USD671636S1 (en) * 2010-04-23 2012-11-27 Daiichi Sankyo Company, Limited Pharmaceutical tablet
USD754841S1 (en) * 2012-02-03 2016-04-26 Johnson & Johnson Consumer Inc. Oral dosage form
USD735315S1 (en) * 2012-06-25 2015-07-28 Celgene Corporation Pharmaceutical tablet
USD755949S1 (en) * 2013-07-30 2016-05-10 Reckitt Benckiser Llc Tablet
USD787042S1 (en) * 2015-04-28 2017-05-16 Celgene Corporation Pharmaceutical tablet
USD813372S1 (en) * 2017-02-22 2018-03-20 Celgene Corporation Pharmaceutical tablet
USD835257S1 (en) * 2017-02-22 2018-12-04 Celgene Corporation Pharmaceutical tablet
USD835258S1 (en) * 2017-02-22 2018-12-04 Celgene Corporation Pharmaceutical tablet

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD918377S1 (en) * 2017-10-11 2021-05-04 Johnson & Johnson Consumer Inc. Tablet
USD947358S1 (en) * 2019-03-19 2022-03-29 Novo Nordisk A/S Pill
USD1017017S1 (en) * 2021-12-20 2024-03-05 Pfizer Inc. Pill

Similar Documents

Publication Publication Date Title
USD886412S1 (en) Undergarment
USD870790S1 (en) Webcam
USD848160S1 (en) Screen
USD832945S1 (en) Football
USD848159S1 (en) Screen
USD886324S1 (en) Telephone booth
USD814814S1 (en) Stool
USD802884S1 (en) Cardiac patient gown
USD811859S1 (en) Cable fastener
USD829266S1 (en) Photography tripod
USD735419S1 (en) Outer shell member for an earmuff
USD829267S1 (en) Photography tripod
USD806674S1 (en) Headset
USD810951S1 (en) Medical vest
USD891500S1 (en) Camera
USD793554S1 (en) Endoscope video processor
USD818781S1 (en) Zester
USD818024S1 (en) Panoramic camera
USD875084S1 (en) Surround for loudspeaker
USD850394S1 (en) Television set
USD787363S1 (en) Wearable ring
USD838839S1 (en) Mouthpiece for medical purposes
USD848602S1 (en) Connector for oxygen mask
USD875392S1 (en) Handbag
USD907760S1 (en) Orally ingestible tablet

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY